کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
961369 929842 2008 18 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Market incentives and pharmaceutical innovation
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی سیاست های بهداشت و سلامت عمومی
پیش نمایش صفحه اول مقاله
Market incentives and pharmaceutical innovation
چکیده انگلیسی
I study the impact of the Orphan Drug Act (ODA), which established tax incentives for rare disease drug development. I examine the flow of new clinical drug trials for a large set of rare diseases. Among more prevalent rare diseases, the ODA led to a significant and sustained increase in new trials. The impact for less prevalent rare diseases was limited to an increase in the stock of drugs. Tax credits can stimulate R&D; yet because they leave revenue margins unaffected, tax credits appear to have a more limited impact on private innovation in markets with smaller revenue potential.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Health Economics - Volume 27, Issue 4, July 2008, Pages 1060-1077
نویسندگان
,